BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FGF21
,
T cell differentiation
,
Obesity
,
Heart
,
Nosology
,
Lovastatin
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CCG1423
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
PC-3 cells treated with CCG-1423, Latrunculin B or DRB for 2 or 24hr
Explore Curated Studies Results
Literature
Most Relevant Literature
Rho signaling inhibitor, CCG-1423, inhibits axonal elongation and dendritic complexity of rat cortic…
Enriching the Arsenal of Pharmacological Tools against MICAL2.
SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic mo…
Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related T…
Myocardin‑related transcription factor A nuclear translocation contributes to mechanical overload‑in…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for CCG1423
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ